Daily Archives: October 15, 2014

Frost & Sullivan Commends DianaPlantSciences for Developing Greener and Smarter Plant Cell Cultures

— DianaPlantSciences’ technology consists in the controlled culture of plant cells producing specific desired plant components, thus eliminating the need to grow the entire plant PORTLAND, Ore., Oct. 16, 2014…

Tianyin Pharmaceutical Provides Update on Filing of Form 10-K for Fiscal Year Ended June 30, 2014

CHENGDU, China, October 15, 2014 /PRNewswire/ — Tianyin Pharmaceutical Inc. (NYSE MKT: TPI, the “Company”), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized…

Mindray Medical to Exhibit New Products at Upcoming Medical Equipment Fairs

SHENZHEN, China, October 15, 2014 /PRNewswire/ — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it will exhibit…

Finesse Introduces SmartVessel™, A Single-Use 3L vessel with Integrated Sensors for Cell Culture

SANTA CLARA, Calif., Oct. 15, 2014 /PRNewswire/ — Finesse Solutions, Inc, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of beta…

ScinoPharm Recognized as API Supplier of the Year at Global Generics & Biosimilars Awards

TAINAN, October 15, 2014 /PRNewswire/ — ScinoPharm (TWSE:1789) announced that it was named the “Active Pharmaceutical Ingredient (API) Supplier of the Year” at the Global Generics and Biosimilars Awards co-hosted…

Complementary Medicine Use Linked to Healthcare Cost Savings, Finds Frost & Sullivan

– Targeted use of complementary medicines significantly reduces risk of disease-related events, hospitalisation costs and productivity losses SYDNEY, Oct. 15, 2014 /PRNewswire/ — Escalating healthcare costs associated with the increasing…

“Steroids OUT!” A Korean Medicine Doctor Banning Chemical Medicine

-New Yorkers with Severe Lung Diseases, Here is Your Rescue! SEOUL, South Korea, October 15, 2014 /PRNewswire/ — “About 123,000 patients with atopic dermatitis, rhinitis, and asthma and 32,000 patients…

Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel

SAN DIEGO, Oct. 15, 2014 /PRNewswire/ — Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, announced today positive results from recently analyzed…